drugset / Trial / NCT00596063

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.

NCT00596063

Phase 1 Completed 25 enrolled Wockhardt
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is the comparative evaluation of the pharmacokinetics and pharmacodynamics of two recombinant regular human insulin injections administered subcutaneously in healthy volunteers under the conditions of euglycemic clamp.

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.2 iu/kg Subcutaneous
Subject Wosulin R Protein / enzyme biologic 0.2 iu/kg Subcutaneous

Indications